ROCHE PRODUCTS LIMITED
Company Information
- Company Number
- 00100674
- Registered Address
- 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW
- Status
- Active
- Employee Count
- 1,476
- Turnover
- £1,081,031,000
- EBITDA
- £61,786,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 14 December 1908
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods72190 - Other research and experimental development on natural sciences and engineering
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 12 Aug 2025 | 43 | 30% | 58% | 12% | 9% |
| 01 Jul 2024 - 31 Dec 2024 | 09 Apr 2025 | 50 | 89% | 8% | 3% | 36% |
| 01 Jan 2024 - 30 Jun 2024 | 26 Mar 2025 | 43 | 81% | 16% | 3% | 19% |
| 01 Jul 2020 - 31 Dec 2020 | 11 Jan 2021 | 32 | 55% | 38% | 7% | 7% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 39 | 50% | 42% | 8% | 6% |
| 01 Jul 2019 - 31 Dec 2019 | 06 Feb 2020 | 35 | 48% | 45% | 7% | 10% |
| 01 Jan 2019 - 30 Jun 2019 | 22 Jul 2019 | 35 | 50% | 46% | 4% | 9% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Our standard payment terms are 60 days from invoice date, but our payment terms are negotiated on a case by case basis.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
120
Dispute Resolution Process
1) Disputed invoices are queried with the supplier immediately after the discrepancy is noticed. Most common queries are in relation to pricing, quantities and missing purchase order numbers. Queries are made in writing and list the type of query and all the required details. The invoices are then held pending resolution. This process is owned by our Accounts payable team. 2) Accounts payable deal with the supplier responses and process credit notes to release invoice payments. 3) Accounts payable liaise with internal points of contact to get the queries resolved as soon as possible. 4) Accounts payable liaise with suppliers to obtain and process any missing invoices and to confirm payment details.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
Roche Products Limited is a leading pharmaceutical company in the United Kingdom, specializing in the development and distribution of innovative medicines and diagnostic tools
The company is a subsidiary of the global healthcare company, Roche Group, and has been operating in the UK for over a century.\n\nSustainability is a key focus for Roche Products Limited, as they recognize the importance of preserving the environment and promoting ethical business practices
The company has implemented various initiatives to reduce their environmental impact, such as minimizing waste and reducing carbon emissions
They also prioritize sustainable sourcing and ethical manufacturing practices in their supply chain.\n\nRoche Products Limited offers a wide range of products and services in the fields of oncology, immunology, infectious diseases, and central nervous system disorders
Their portfolio includes both prescription medicines and diagnostic tools, such as advanced cancer treatments, HIV diagnostic tests, and multiple sclerosis therapies
The company is committed to continuous research and development to provide patients with innovative and effective treatments.\n\nThe key people at Roche Products Limited include the managing director, Dr
Paul Catchpole, who has over 25 years of experience in the pharmaceutical industry, and the head of sustainability, Ms
Annelisa Grigg, who leads the company's sustainability efforts
They are supported by a team of dedicated professionals who work towards achieving the company's goals.\n\nFor any inquiries or information about Roche Products Limited, their website (https://www.roche.co.uk/) serves as a comprehensive resource
The registered office address is Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom
Customers can also contact the company through their customer care hotline at 0800 731 5711
Overall, Roche Products Limited is committed to sustainable business practices and providing high-quality healthcare solutions to improve the lives of patients in the UK and around the world